Early versus deferred treatment for smoldering multiple myeloma: a meta-analysis of randomized, controlled trials.
Whether patients with smoldering multiple myeloma (SMM) needed to receive early interventional treatment remains controversial. Herein, we conducted a meta-analysis comparing the efficacy and safety of early treatment over deferred treatment for patients with SMM.MEDLINE and Cochrane Library were se...
Main Authors: | Minjie Gao, Guang Yang, Van S Tompkins, Lu Gao, Xiaosong Wu, Yi Tao, Xiaojing Hu, Jun Hou, Ying Han, Hongwei Xu, Fenghuang Zhan, Jumei Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4184905?pdf=render |
Similar Items
-
Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies
by: Zhao AL, et al.
Published: (2019-06-01) -
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
by: Eileen M. Boyle, et al.
Published: (2021-01-01) -
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
by: Efrat Markus, et al.
Published: (2020-05-01) -
Genomic patterns of progression in smoldering multiple myeloma
by: Bolli, N, et al.
Published: (2018) -
Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01)